Literature DB >> 8376822

Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City.

M Y Stoeckle1, L Guan, N Riegler, I Weitzman, B Kreiswirth, J Kornblum, F Laraque, L W Riley.   

Abstract

Isoniazid resistance in Mycobacterium tuberculosis is associated with lack of catalase-peroxidase activity. A recent study showed that some isoniazid-resistant M. tuberculosis strains have a complete deletion of the gene (katG) encoding this enzyme. To examine what proportion of clinical isolates of M. tuberculosis have katG deletion, katG sequences in 80 randomly selected isolates from New York City were analyzed. Polymerase chain reaction was used to amplify a 282-bp segment of M. tuberculosis katG and showed that 35 (90%) of 39 isoniazid-sensitive and 31 (76%) of 41 isoniazid-resistant strains contained katG sequences (P > .1). Ten multidrug and high-level isoniazid-resistant strains with identical restriction fragment length polymorphism patterns were also analyzed. All were found to have katG sequences. These findings suggest that mechanisms other than complete deletion of katG are involved in isoniazid resistance among most clinical isolates of M. tuberculosis from New York City.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376822     DOI: 10.1093/infdis/168.4.1063

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.

Authors:  A Telenti; N Honoré; C Bernasconi; J March; A Ortega; B Heym; H E Takiff; S T Cole
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

2.  Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan.

Authors:  H Ohno; H Koga; S Kohno; T Tashiro; K Hara
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

3.  katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients.

Authors:  H J Marttila; H Soini; P Huovinen; M K Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

4.  Presence of katG gene in resistant Mycobacterium tuberculosis.

Authors:  M Jaber; A Rattan; R Kumar
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

5.  Identification, cloning, and expression of the Escherichia coli pyrazinamidase and nicotinamidase gene, pncA.

Authors:  R Frothingham; W A Meeker-O'Connell; E A Talbot; J W George; K N Kreuzer
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

6.  Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors.

Authors:  Christopher W am Ende; Susan E Knudson; Nina Liu; James Childs; Todd J Sullivan; Melissa Boyne; Hua Xu; Yelizaveta Gegina; Dennis L Knudson; Francis Johnson; Charles A Peloquin; Richard A Slayden; Peter J Tonge
Journal:  Bioorg Med Chem Lett       Date:  2008-04-18       Impact factor: 2.823

7.  Prospective study of drug-resistant tuberculosis in a Spanish urban population including patients at risk for HIV infection.

Authors:  V Ausina; N Riutort; B Viñado; J M Manterola; J Ruiz Manzano; C Rodrigo; L Matas; M Giménez; J Tor; J Roca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

8.  First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance.

Authors:  Rocio Lopez-Alvarez; Claudia Badillo-Lopez; Jorge F Cerna-Cortes; Ivan Castillo-Ramirez; Sandra Rivera-Gutierrez; Addy C Helguera-Repetto; Diana Aguilar; Rogelio Hernandez-Pando; Sofia Samper; Jorge A Gonzalez-y-Merchand
Journal:  BMC Microbiol       Date:  2010-03-17       Impact factor: 3.605

9.  Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductase.

Authors:  Hui Wang; Li Liu; Yang Lu; Pan Pan; Jacob M Hooker; Joanna S Fowler; Peter J Tonge
Journal:  Bioorg Med Chem Lett       Date:  2015-07-14       Impact factor: 2.823

10.  Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Authors:  Indra L Bergval; Anja R J Schuitema; Paul R Klatser; Richard M Anthony
Journal:  J Antimicrob Chemother       Date:  2009-07-04       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.